Zürcher Kantonal Bank

embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.

Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.

Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

UniSieve Ltd, founded in 2018 and headquartered in Zurich, Switzerland, develops and manufactures advanced molecular sieving membranes that enable efficient separation solutions across various industries. The company's innovative platform technology integrates molecular sieves with polymeric membranes to facilitate applications such as chemical feedstock purification, biogas upgrading, gas and liquid separation, and specialized uses in sensing and space-related projects. UniSieve's technology is designed to enhance energy efficiency in size-based purification processes, supporting clients in reducing carbon dioxide emissions, improving recycling rates, and lowering operational costs.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in manufacturing 3D printers that produce carbon composite parts. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Utilizing its proprietary Additive Fusion Technology (AFT), 9T Labs enables manufacturers to create lightweight structural components with precise 3D fiber orientation, facilitating mass production at reduced costs. The intuitive design software supports optimal fiber placement, while automated production equipment enhances efficiency across the entire value chain. The technology allows for the efficient production of high-performance parts, including applications in drones and prosthetics, making it accessible for engineers and manufacturers alike.

Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

Nexoya AG is a Zurich-based company founded in 2018 that specializes in developing a digital marketing platform designed to enhance marketing performance through artificial intelligence. The platform provides insights into marketing data and actionable advice, allowing clients to optimize their marketing campaigns and effectively allocate their advertising budgets across various channels. By collecting key performance indicators from tools such as Google Ads and Facebook, Nexoya's AI-driven algorithm evaluates the most cost-effective use of advertising funds, leading to a potential increase in return on ad spend. The platform also features predictive analytics, cross-channel reporting, and anomaly detection, which assist clients in planning and executing their marketing strategies with maximum efficiency.

Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform aimed at treating various health conditions, particularly infections and blood-related diseases. Utilizing innovative magnetic blood purification technology, Hemotune's device employs magnetic beads to selectively and efficiently remove large biomolecules from the bloodstream. This approach focuses on addressing the immunological aspects of sepsis, enabling the targeted treatment of multiple disease pathways and improving patient outcomes in acute care settings.

Positrigo AG is a Swiss company based in Zurich that specializes in the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on making functional brain imaging accessible for early detection of neurodegenerative diseases, particularly Alzheimer's disease. The company provides advanced scanning solutions that aid in diagnostics, treatment monitoring, and the development of new therapies for conditions such as Lewy body dementia, vascular dementia, and frontotemporal dementia. By enabling early diagnosis in an affordable manner, Positrigo aims to improve patient outcomes and support healthcare professionals in managing these complex medical conditions.

Skribble is a Zurich-based platform that specializes in electronic signatures, enabling users to sign contracts digitally while ensuring that these signatures carry the same legal weight as handwritten ones under Swiss and EU law. Founded in 2018, Skribble provides a user-friendly interface that allows individuals and businesses to sign documents with a few clicks, streamlining the process of contract management. The platform incorporates signature management systems that facilitate the identification of signers, ensuring compliance with legal requirements. Through its services, Skribble aims to simplify the process of creating legally binding agreements in a digital format.

Klepsydra Technologies GmbH, founded in 2017 and based in Zurich, Switzerland, specializes in software engineering and cloud computing tools for embedded systems. The company provides a lightweight, platform-agnostic software development toolset aimed at facilitating the creation of high-performance applications in sectors such as aerospace, robotics, and smart mobility. Klepsydra's offerings are designed to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks, such as sensor fusion and image processing. By enabling faster and more accessible innovation processes, Klepsydra serves as a valuable resource across various industries, contributing to advancements in autonomous technologies and other computationally intensive applications.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

Yonder AG is a Swiss company, founded in 2015 and based in Zurich, that specializes in documentation-as-a-service (DaaS) solutions. The company's primary offering, Yonder Mind, is an application software designed for information management, enabling organizations to create, maintain, and deliver relevant content to users efficiently. Yonder AG also offers services related to document content creation and conversion, helping clients streamline information dissemination through shorter documents and manageable revisions.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.

Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Climeworks AG is a Swiss company founded in 2009 that specializes in developing and commercializing technology for capturing carbon dioxide (CO2) directly from the atmosphere. The company operates modular direct air capture plants that utilize filters and primarily low-grade heat as an energy source to extract CO2. This captured CO2 is then supplied to various industries, including commercial agriculture, food and beverage, energy, and automotive. Clients employ this atmospheric CO2 for applications such as carbonated drinks, carbon-neutral hydrocarbon fuels, and materials. Climeworks also supports businesses in achieving their climate objectives by providing solutions for reversing emissions and safely storing the captured CO2, contributing to global efforts to combat climate change.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

TestingTime AG, founded in 2014 and based in Zurich, Switzerland, specializes in online recruitment services for test users, catering primarily to the UX and market research sectors. The company offers a diverse pool of over 350,000 participants, enabling clients to efficiently source individuals for usability tests, interviews, focus groups, and surveys in multiple languages, including German, French, Italian, Romansh, and English. By employing screening processes, predictive machine learning algorithms, and a smart rating system, TestingTime ensures the recruitment of high-quality test users with a low no-show rate. Its services are utilized by notable corporations such as UBS, Zalando, Microsoft, and Accenture, facilitating seamless research processes for their clients.

Piavita AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing a matchbox-sized wearable device that precisely measures vital data in pets and horses. Recognizing the increasing demand for high-quality veterinary care, the company addresses the challenges faced by veterinarians in diagnosing and monitoring animal health due to limited information and outdated practices. Piavita's innovative solution includes a wearable technology that tracks vital signs through an animal's coat without the need for clipping, combined with a web-based application that enables real-time monitoring and historical data access. This system enhances communication between veterinarians and pet owners, aiming to lead the digital transformation in the veterinary industry by providing reliable insights into animal health.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.

Peripal AG is a medical device company based in Zurich, Switzerland, founded in 2015. It specializes in developing and commercializing patient aids for home care patients undergoing dialysis, particularly focusing on Peritoneal dialysis. Notable products include PeriSafe, a patient assist device designed to facilitate the Peritoneal dialysis process, and PERiPLEX, a diagnostic tool for detecting infections associated with this treatment. The company’s primary innovation, the Peripal System, enhances the manual connection of dialysis tubings, addressing the complexities and risks associated with traditional methods. By simplifying the connection process, Peripal aims to empower more patients to perform their dialysis at home, thereby alleviating anxiety for healthcare providers and reducing overall healthcare costs.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

Piavita AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing a matchbox-sized wearable device that precisely measures vital data in pets and horses. Recognizing the increasing demand for high-quality veterinary care, the company addresses the challenges faced by veterinarians in diagnosing and monitoring animal health due to limited information and outdated practices. Piavita's innovative solution includes a wearable technology that tracks vital signs through an animal's coat without the need for clipping, combined with a web-based application that enables real-time monitoring and historical data access. This system enhances communication between veterinarians and pet owners, aiming to lead the digital transformation in the veterinary industry by providing reliable insights into animal health.

Ampard AG, headquartered in Zurich, Switzerland, specializes in the development and marketing of the AMPARD energy management system across Europe. Established in 2011, the company focuses on managing distributed renewable power plants and demand response. The AMPARD system, a leading swarm energy management solution, optimizes control of renewable assets and storage systems, facilitates the creation of virtual power plants, and integrates other devices for demand response. Ampard's innovative technology enables efficient control and distribution of renewable energy, positioning it at the forefront of global innovation in the sector.

Climeworks AG is a Swiss company founded in 2009 that specializes in developing and commercializing technology for capturing carbon dioxide (CO2) directly from the atmosphere. The company operates modular direct air capture plants that utilize filters and primarily low-grade heat as an energy source to extract CO2. This captured CO2 is then supplied to various industries, including commercial agriculture, food and beverage, energy, and automotive. Clients employ this atmospheric CO2 for applications such as carbonated drinks, carbon-neutral hydrocarbon fuels, and materials. Climeworks also supports businesses in achieving their climate objectives by providing solutions for reversing emissions and safely storing the captured CO2, contributing to global efforts to combat climate change.

zkipster GmbH is an event management platform based in Zurich, Switzerland, founded in 2009. The company specializes in providing comprehensive tools for managing live, virtual, and hybrid events. Its offerings include a range of features such as guest list management, custom email and SMS communications, real-time session management, and dynamic seating charts. Additionally, zkipster's solutions enable efficient check-in processes through the use of QR codes and facilitate insightful event analysis. The platform is designed to enhance the guest experience and streamline event planning for global brands and renowned organizations. One of its key technologies is zFace, a picture matching search engine integrated into its guest list solution, which is accessible on various devices including iPads, iPhones, and Windows 8 systems.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

Aeon Scientific AG is a medical device company based in Schlieren, Switzerland, that specializes in the development of innovative medical equipment utilizing patented electromagnetic steering technology. Founded in 2010, the company focuses on creating tools that enhance the effectiveness, safety, and minimally invasive nature of medical procedures, particularly in the field of electrophysiology. Its flagship product, Cmag, is a magnetic catheter steering system designed to assist electrophysiologists during catheter ablation procedures for treating arrhythmias like atrial fibrillation. By facilitating the precise movement of ablation catheters through the heart using magnetic fields, Aeon Scientific aims to improve patient outcomes while reducing healthcare costs. The company seeks to expand its offerings to include comprehensive toolkits for various medical applications and is open to partnerships with other medical device manufacturers to foster innovation in the industry.

pearltec AG, based in Schlieren/Zurich, Switzerland, specializes in developing and providing innovative patient positioning systems for healthcare professionals. Founded in 2008, the company offers a range of products including the Multipad for general positioning, Crania Adult and Crania Child for head scans, and Genus Adult and Genus Child for knee scans. Their solutions are underpinned by patented technology developed in collaboration with ETH Zurich and leading university hospitals. Committed to enhancing patient care, pearltec AG aims to leverage its technological expertise to create value for customers, ensuring high-quality products with practical application advantages. The company is also certified under ISO standard 13485, affirming that its quality management system for medical device development and manufacturing adheres to rigorous international standards.

Aeon Scientific AG is a medical device company based in Schlieren, Switzerland, that specializes in the development of innovative medical equipment utilizing patented electromagnetic steering technology. Founded in 2010, the company focuses on creating tools that enhance the effectiveness, safety, and minimally invasive nature of medical procedures, particularly in the field of electrophysiology. Its flagship product, Cmag, is a magnetic catheter steering system designed to assist electrophysiologists during catheter ablation procedures for treating arrhythmias like atrial fibrillation. By facilitating the precise movement of ablation catheters through the heart using magnetic fields, Aeon Scientific aims to improve patient outcomes while reducing healthcare costs. The company seeks to expand its offerings to include comprehensive toolkits for various medical applications and is open to partnerships with other medical device manufacturers to foster innovation in the industry.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

basisnote AG was established on October 4, 2007 by an interdisciplinary team at the Federal Institute of Technology in Zurich. The founders are biologist Dr. August Hämmerli, physicist Manuel Kaegi and social scientist Dominic Senn. basisnote is developing test procedures that make it possible to establish the specific scent profile of any individual. The process has made use of findings from scientific research in the fields of scent and mate selection. The basisnote scent matching procedure, in which two profiles are compared with one another, reveals how well two people are suited to one another as far as scent is concerned. It substitutes for the human nose in online dating platforms.

Locatee AG is a Zurich-based company that specializes in workplace analytics solutions aimed at optimizing office space utilization. Founded in 2014, Locatee offers an innovative analytics platform that measures office occupancy without the need for hardware. By leveraging data from various sources, the platform processes this information using patented technology to provide clear insights into space utilization. This empowers corporate leaders and managers to make informed decisions regarding their real estate portfolios. The solution not only highlights optimization opportunities but also helps organizations achieve cost savings and improve the overall workplace experience. Through intelligent analytics and user-friendly reporting features, Locatee addresses the challenges of modern corporate real estate.